The US Compounding Pharmacies Market Analysis: $6.21 Billion Opportunities In The Next 6 Years – Arizton
The US Compounding Pharmacies Market Analysis: $6.21 Billion Opportunities In The Next 6 Years – Arizton . (MENAFN - GetNews)  "U.S. Compounding Pharmacies Market Research Report by Arizton"
According to Arizton's latest research report, the US compounding pharmacies market is growing at a CAGR of 4.06% ...
América - MenaFN
(MENAFN- GetNews)





"U.S. Compounding Pharmacies Research Report by Arizton"





According to Arizton's latest research report, the US compounding pharmacies market is growing at a CAGR of 4.06% during 2023-2029.





Looking for More Information? Click:







Report Scope:



Market Size (2029): $6.21 Billion



Market Size (2023): $4.89 Billion



CAGR (2023-2029): 4.06%



Historic Year: 2020-2022



Base Year: 2023



Forecast Year: 2024-2029



Market Segmentation: Product Type, Pharmacy Type, Sterility Type, Compounding Type, Application, Age Cohort





The US compounding pharmacy market occupies a unique position within the broader pharmaceutical industry, offering personalized medications tailored to individual patient needs. This market is driven by the rising demand for customized treatments, particularly for conditions not well-addressed by mass-produced drugs, such as allergies, unique dosage requirements, and specialized medical conditions. The aging population and an increasing prevalence of chronic diseases further fuel the market's growth, as compounded medications can provide alternative formulations, such as liquid or topical versions, for patients who cannot tolerate standard pills.

However, the market faces several challenges, including strict regulatory scrutiny. Compounding pharmacies must comply with both state and federal regulations, particularly after the 2012 fungal meningitis outbreak led to heightened oversight. The Drug Quality and Security Act (DQSA) created more stringent rules for larger operations, adding regulatory complexity. Additionally, smaller pharmacies struggle with the high costs of compliance and maintaining safety and quality standards, while competing with mass-produced pharmaceutical options.





Personalized Oral Medications Drive Growth in US Compounding Pharmacy Market

Oral compounded medications are a vital component of the US compounding pharmacy market, offering personalized solutions for patients when standard commercial medications are unsuitable. These custom medications address issues related to dosage, flavor, and form, improving patient compliance and therapeutic outcomes. Common oral product types include capsules, solutions and suspensions, troches and lozenges, and custom tablets, each tailored to meet specific patient needs, such as those requiring non-standard dosages, those with allergies, or patients who have difficulty swallowing pills.

These medications are crucial in personalized medicine, particularly for pediatric, geriatric, and allergy-sensitive patients. The ability to create customized dosages and remove allergens like gluten or lactose enhances treatment accessibility. Compounding pharmacies can also recreate discontinued medications. However, maintaining high-quality standards is essential, with pharmacies needing to follow strict protocols to ensure the accuracy, safety, and consistency of compounded oral products.





Market Opportunities

The

collaboration between healthcare providers and compounding pharmacies drives personalized care

The US compounding pharmacy market is experiencing growth due to increasing collaboration with healthcare providers. This partnership enables the creation of customized medications that meet individual patient needs, particularly for those with allergies, unique dosage requirements, or specialized conditions. Compounding pharmacies help address drug shortages and discontinuations, ensuring continuity of care. Areas such as pain management, hormone therapy, and pediatric care are seeing significant benefits. Technological advances, including telehealth and e-prescriptions, enhance coordination and patient safety. As demand for personalized medicine rises, these collaborations are transforming treatment outcomes and expanding the scope of services in healthcare.





Competitive Overview

In the highly competitive US compounding pharmacy market, companies are adopting a range of strategies to differentiate themselves and drive growth. With the shift toward personalized medicine, compounding pharmacies are increasingly focusing on niche specialties to carve out unique positions in the healthcare landscape. Many are concentrating on specific therapeutic areas, such as bioidentical hormone replacement therapy (BHRT), pediatric formulations, and veterinary compounding, to address unmet needs not covered by traditional retail pharmacies or mass-produced medications.

To stay ahead, compounding pharmacies are also emphasizing high-quality standards, exceptional customer service, and technological innovation. This focus on quality assurance and advanced technologies helps improve patient outcomes and ensures compliance with stringent regulatory standards.

Sterile compounding, which involves the preparation of injectable medications or eye drops in sterile environments, is another key area of differentiation. Pharmacies excelling in sterile compounding cater to hospitals, clinics, and specialized medical centers, offering critical solutions that set them apart from other players in the market.





Vendor Insights

AVELLA SPECIALTY PHARMACY Avella Specialty Pharmacy enhances patient care with personalized compounded medications and invests in advanced compounding technologies.

CAPS CAPS strengthens partnerships with hospitals to provide sterile compounded medications, ensuring regulatory compliance and quality control.

FAGRON Fagron drives innovation in compounding by focusing on R&D and offering custom formulations, raw materials, and global expertise.

FRESENIUS KABI Fresenius Kabi specializes in compounded injectable medications and infusion solutions, prioritizing quality and safety in critical care.

PENCOL PHARMACY Pencol Pharmacy offers customized medication solutions with a patient-centric approach, ensuring compliance with regulatory standards.





Looking for More Information? Click:







Key Company Profiles



Avella Specialty Pharmacy

CAPS

Fagron

Fresenius Kabi

PenCol Pharmacy

Austin Compounding Pharmacy

Capstone Compounding Pharmacy

Charles River Laboratories

Dougherty's Pharmacy

Eastern States Compounding Pharmacy

Everwell Specialty Pharmacy

Harrow

Hill's Compounding Pharmacy and Milford Pharmacy

INNOVATIVE RX

Institutional Pharmacy Solutions

ITC Compounding Pharmacy

McGuff Company

MediVera Compounding Pharmacy

Nephron Pharmaceuticals

PCCA

Precision Compounding Pharmacy

QuVa Pharma

Sixth Avenue Medical Pharmacy

St. Anthony Pharmacy

The Compounding Pharmacy of America

Triangle Compounding

Valor Compounding Pharmacy Vertisis Custom Pharmacy





Market Segmentation





Product Type



Oral

Topical

Parenteral

Ophthalmic Others





Pharmacy Type



503A 503B





Sterility Type



Sterile Non-sterile





Compounding Type



Pharmaceutical Ingredient Alteration (PIA)

Currently Unavailable Pharmaceutical Manufacturing (CUPM) Pharmaceutical Dosage Alteration (PDA)





Application



Pain Management

Hormone Replacement Therapy

Anti-aging & Skin Care

Nutritional Supplements Others





Age Cohort



Adult

Geriatric Pediatric





The Arizton Advisory & Intelligence market research report provides valuable market insights for industry stakeholders, investors, researchers, consultants, and business strategists aiming to gain a thorough understanding of the US compounding pharmacies market. Request for Free Sample to get a glance of the report now:





What Key Findings Our Research Analysis Reveals?



How big is the U.S. compounding pharmacies market?

What is the growth rate of the U.S. compounding pharmacies market?

What are the significant trends in the U.S. compounding pharmacies market?

Which compounding type segment dominates the U.S. compounding pharmacies market share?

Who are the key players in the U.S. compounding pharmacies market?





Looking for Customization According to Your Business Requirement?





Other Related Reports that Might be of Your Business Requirement



Global Online Pharmacy Market - Focused Insights 2024-2029

U.S. Pharmacy Benefit Management Market - Industry Outlook & Forecast 2024-2029





Why Arizton ?



100% Customer Satisfaction



24x7 availability – we are always there when you need us



200+ Fortune 500 Companies trust Arizton's report



80% of our reports are exclusive and first in the industry



100% more data and analysis



1500+ reports published till date







Post-Purchase Benefit





1hr of free analyst discussion

10% off on customization







About Us:



Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.



We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.



Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108937021/The-US-Compounding-Pharmacies-Market-Analysis-621-Billion-Opportunities-In-The-Next-6-Years-Arizton
2024-11-28
rss
(MENAFN - GetNews)  "U.S. Compounding Pharmacies Market Research Report by Arizton"
According to Arizton's latest research report, the US compounding pharmacies market is growing at a CAGR of 4.06% ...
The US Compounding Pharmacies Market Analysis: $6.21 Billion Opportunities In The Next 6 Years – Arizton